NCT02528110View on ClinicalTrials.gov

Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions
Malignant Neoplasm of Stomach
Interventions
PROCEDURE

Hyperthermic intraperitoneal chemotherapy (HIPEC)

Normal saline 3000ml-4000ml, Paclitaxel 75mg/m2, 5-Fu 15mg/m2, 43°C, 60min.

PROCEDURE

D2 radical gastrectomy

radical gastrectomy with D2 lymphadenectomy

OTHER

SOX postoperative chemotherapy

Oxaliplatin 130mg/m2 d1, Tegafur,Gimeracil and Oteracil Porassium Capsules 60mg, d1-14.

OTHER

XELOX postoperative chemotherapy

Oxaliplatin 130mg/m2 d1, Capecitabine 1000mg/m2 d1-14.

Trial Locations (1)

430021

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Wuhan University

OTHER

NCT02528110 - Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter